Related Experiment Video
Updated: Nov 8, 2025

05:12
Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
4.1K
[The Therapy of Malignant Thyroid Disease from ENT-Perspective]
Peter Rolf Issing1, Torsten Köhler1, Hendrik Tebben1
1Klinik für Hals-Nasen-Ohrenheilkunde, Klinikum Bad Hersfeld GmbH, Bad Hersfeld, Germany.
Laryngo- Rhino- Otologie
|April 27, 2021
Summary
This study highlights the rising incidence of thyroid cancer, with papillary carcinoma being the most common type. While differentiated thyroid cancers had a low mortality rate, anaplastic thyroid carcinomas were uniformly fatal.
Area of Science:
- Otorhinolaryngology
- Endocrine Surgery
- Oncology
Background:
- Thyroid gland malignancies are increasing in incidence.
- The ENT department in Bad Hersfeld has focused on thyroid disorder management.
- This study shares clinical experiences in managing thyroid disorders.
Purpose of the Study:
- To evaluate demographic and medical parameters of patients with malignant thyroid disease.
- To analyze the outcomes of thyroid cancer management.
- To emphasize the role of otorhinolaryngologists in thyroid cancer care.
Main Methods:
- Retrospective analysis of 63 patients with malignant thyroid disease from 2014 to July 2020.
- Evaluation of patient data including age, sex, histology, and treatment modalities.
- Surgical management followed by radioiodine therapy for advanced differentiated carcinomas.
Main Results:
- Papillary thyroid carcinoma was the most prevalent type (65%).
- Differentiated thyroid cancers had a significantly lower mortality rate compared to anaplastic carcinomas.
- Two cases of parathyroid carcinoma were incidentally discovered in patients with primary hyperparathyroidism.
Conclusions:
- Otorhinolaryngologists play a crucial role in managing thyroid malignancies.
- Interdisciplinary collaboration is essential for achieving high standards in endocrine neck organ disease management.
- Effective management strategies are vital for improving outcomes in thyroid cancer patients.
Related Concept Videos
The Thyroid Gland
5.3K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
5.3K
Synthesis and Regulation of Thyroid Hormones
6.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
6.1K
The Tumor Microenvironment
7.2K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.2K
Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
Tumor Immunotherapy
807
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
807
Functions of Thyroid Hormones
4.0K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
4.0K

